Status:
COMPLETED
PROSTACOX : Metastatic Prostate Chemotherapy
Lead Sponsor:
University Hospital, Rouen
Conditions:
Metastatic Prostate Cancer
Eligibility:
MALE
Brief Summary
Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.
Detailed Description
Association Docetaxel (J 15) and celecoxib Patient survival Biological parameter : PSA Clinical status RECIST evaluation
Eligibility Criteria
Inclusion
- metastatic prostate cancer
- ASCO progression criteria
Exclusion
- other prostate chemotherapy
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
End Date :
June 1 2006
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00213694
Start Date
November 1 2003
End Date
June 1 2006
Last Update
March 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles Nicolle, University Hospital
Rouen, France, 76031